Disc Medicine (IRON) Equity Average (2020 - 2026)

Disc Medicine (IRON) has 7 years of Equity Average data on file, last reported at $714.1 million in Q1 2026.

• Equity Average for Q1 2026 came in at $714.1 million, up 29.38% year-over-year; the trailing twelve-month figure through Mar 2026 was $714.1 million (up 29.38% YoY), and the FY2025 annual result was $591.7 million, up 50.04% from the prior year.
• Equity Average advanced to $714.1 million in Q1 2026 per IRON's latest filing, from $656.6 million in the prior quarter.
• Over five years, Equity Average peaked at $714.1 million in Q1 2026 and troughed at -$90.7 million in Q3 2022.
• A 5-year average of $345.2 million and a median of $365.1 million in 2023 frame the typical range for Equity Average.
• The sharpest annual moves came in 2022 and 2023: Equity Average sank 196.85% in 2022, then jumped 801.84% in 2023.
• A 5-year view of Equity Average shows it stood at $39.0 million in 2022, then jumped by 801.84% to $352.0 million in 2023, then increased by 29.46% to $455.8 million in 2024, then jumped by 44.06% to $656.6 million in 2025, then grew by 8.76% to $714.1 million in 2026.
• Business Quant data shows IRON's Equity Average at $714.1 million in Q1 2026, $656.6 million in Q4 2025, and $593.8 million in Q3 2025.